Pulse Biosciences (PLSE)Director bought ~$189K
Robert W Duggan, Director at Pulse Biosciences, bought ~$189K of Pulse Biosciences shares.
- ~$189K
- Approx. value · 13K sh @ $14.77
- 47.6M
- Holds after · shares reported
- Traded
- Sep 11, 2024
- Filed
- Sep 13, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
What came next
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Pulse Biosciences
OQRO holds no insider, Congress, fund or contract record for Pulse Biosciences dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PLSE page.
Other recent filings by Robert W Duggan, Director
- SEC Form 4 at Pulse Biosciences (PLSE)Sep 13, 2025
- SEC Form 4 at Pulse Biosciences (PLSE)Sep 13, 2025
- SEC Form 4 at Summit Therapeutics (SMMT)Sep 11, 2025
- SEC Form 4 at Summit Therapeutics (SMMT)Sep 11, 2025
- SEC Form 4 at Pulse Biosciences (PLSE)Dec 18, 2024
The full history of Robert W Duggan, Director is on the profile page.
How this filing works
Other disclosures at Pulse Biosciences
- SEC Form 4Sep 23, 2025
- SEC Form 4Sep 23, 2025
- SEC Form 4Sep 19, 2025
- SEC Form 4Sep 19, 2025
- SEC Form 4Sep 16, 2025
- SEC Form 4Sep 16, 2025
Everything OQRO holds on this company is on its PLSE page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
